LeaderPortfolio
Bancel
Stéphane Bancel
Rank #2305
FRANCEHealthcareBiotech, vaccines

Stéphane Bancel

Net Worth
$1.787B
-0.95% (24h)
Stéphane Bancel is the CEO of Moderna, a leading biotechnology company focused on mRNA therapeutics, particularly vaccines. Born in Marseille, France, Bancel, at 53 years old, has a net worth of $2.0 billion, stemming from his expertise in biotech and vaccines. He earned an MBA from Harvard Business School and holds master's degrees from École Centrale Paris and the University of Minnesota. His career includes leadership roles at BioMérieux and Eli Lilly before joining Moderna in 2011. Bancel was nominated Chevalier of the Legion d'honneur in 2022 and was elected to the U.S. National Academy of Engineering in 2024.

The Full Dossier

Early Life

Stéphane Bancel was born in Marseille, France. His father was an engineer, and his mother was a doctor. Bancel enjoyed science and mathematics during his childhood. He studied engineering at École Centrale Paris (CentraleSupélec) and biological engineering at the University of Minnesota, earning master's degrees at both institutions. He later earned an MBA from Harvard Business School.

Rise to Success

Bancel's career began at Eli Lilly and Company and bioMérieux SA, where he served as CEO. In 2011, he became the CEO of Moderna. Under his leadership, Moderna developed and commercialized the COVID-19 vaccine, which generated significant revenue and propelled the company to prominence.

Key Business Strategies

Bancel has focused on mRNA technology for developing drugs and vaccines. He has expanded the company's research into oncology, cardiovascular disease, and rare genetic diseases. Bancel has also emphasized cost-cutting measures to achieve profitability.

Philanthropy

Bancel pledged to donate all after-tax proceeds from his original Moderna stock options to charity. The donation is estimated to be worth approximately $355 million.

Career Timeline

2024

Elected to the U.S. National Academy of Engineering

Recognized for his contributions to engineering.

2022

Nominated Chevalier of the Legion d'honneur

Recognized with the highest recognition in France.

2011

CEO of Moderna

Joined Moderna as CEO.

2007

CEO of BioMérieux

Became CEO of French diagnostics company BioMérieux.

2000

Various roles at Eli Lilly and Company

Served in various roles, including managing director for Belgium and executive director of global manufacturing strategy and supply chain.

Philanthropic Impact

General Philanthropy$355M

Bancel Philanthropies

Donates to people and programs with the potential to transform lives, advance social justice, and heal communities.

Wealth Trajectory